PharmaForceIQ Announces Substantial Growth as it Expands Optichannel Engagement Solutions

PharmaForceIQ has announced a period of significant growth as it goes beyond omnichannel to optichannel campaign solutions. The company is the fastest growing independent provider of precision customer engagement technologies for the Life Science industry, and it has experienced a multifold increase in average contract value in the past year. In one client, the company expanded from a pilot campaign for one specialty brand to their entire specialty pharmaceutical portfolio in only 7 months. PharmaForceIQ also has a 100% client renewal rate – demonstrating that its data-driven strategies deliver unmatched efficiency and tangible results

Dr Quin Wills Appointed as Ochre Bio CEO

Oxford-based Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, has appointed Dr Quin Wills as CEO.

Takara Bio Europe signs distribution agreement with MACHEREY-NAGEL to expand access to high-quality bioanalysis products

Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL to expand access to high-quality bioanalysis products.

Spartanburg Regional Healthcare System (SRHS) Deploys 2bPrecise Enterprise

Rewriting the Timeline of Detection: Linus Health's Digital Platform Uncovers the Earliest Signs of Cognitive Decline

Rewriting the Timeline of Detection: Linus Health's Digital Platform Uncovers the Earliest Signs of Cognitive Decline

Laverock Therapeutics expands seed funding and announces key milestone progress

Laverock Therapeutics closes additional seed funding round, bringing total raised to more than £20m, and announces key data

Baylor Genetics Applauds New Guidance from American Academy of Pediatrics for Genome and Exome Sequencing to be used as First-Tier Tests for Children with Certain Developmental Delays

Baylor Genetics, a leading clinical diagnostic laboratory at the forefront of genetic testing, today announced its support for the American Academy of Pediatrics’ (AAP) updated guidance recommending whole genome and whole exome sequencing as first-tier tests. Baylor Genetics has long recognized the value of these tests, and offers a comprehensive, structured framework to help pediatricians promptly identify potential genetic causes in children presenting with global developmental delay (GDD) or intellectual disability (ID). This milestone empowers pediatricians, supported by genetics professionals, with access to earlier and more comprehensive insights that guide clinical decisions for patients and their families, marking a critical step toward faster diagnoses and improved outcomes.

InSysBio to announce extension of collaboration with discoveric bio alpha

The project aims at translational mechanistic modeling of antibodies to predict human pharmacokinetics and target occupancy in cerebrospinal fluid

Alithea Genomics Announces the Launch of MERCURIUS™ FLASH-seq: A Plate-Based, Full-Length Single Cell RNA-seq Kit Delivering Exceptional Sensitivity and Simplicity

Alithea Genomics has announced the commercial launch of MERCURIUS™ FLASH-seq, a next-generation library preparation kit for full-length single-cell RNA sequencing.

Insilico Medicine Completes First-in-Patient Dosing of ISM3412, the Novel MAT2A Inhibitor for the Treatment of Locally Advanced/​Metastatic Solid Tumors

ISM3412 was designed with the support of Chemistry42, Insilico’s proprietary generative chemistry engine, for the treatment of locally advanced and metastatic solid tumors. The Phase I study of ISM3412 is currently recruiting in multiple sites across the United States and China, aiming to evaluate the safety, tolerability, PK/PD profiles and preliminary efficacy in patients.

Ambience Healthcare's "Patient Recap" Offers Clinicians the First Chart Summarization Technology from an Ambient AI Platform

ResultsCX Earns Great Place To Work® Certification™ in Seven Countries, Including First Time Recognition in India and the UK

Phastar appoints Industry Veteran Billy Amzal as Head of Strategic Consulting

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), today announced the appointment of Billy Amzal as Head of Strategic Consulting.

Association for Molecular Pathology Publishes Best Practice Recommendations for Clinical HRD Testing

AMP recently published a new report with 12 best practice recommendations focused on the design and validation of clinical HRD assays. To develop these recommendations, AMP assembled an expert panel that included organizational representation from ACCC, ASCO, and the CAP.

Avalon 2025 Lab Trend Report: Genetic Testing Soars as Routine Testing Stabilizes

Avalon 2025 Lab Trend Report: Genetic Testing Soars as Routine Testing Stabilizes

New Collaboration Initiative: Alfa Chemistry Announces Inclusion as a Listed Supplier across CHEMnetBASE Dictionaries

To make it easier for researchers to find and access the specialized chemicals they need, Alfa Chemistry has announced that it has been added as a supplier to the CHEMnetBASE dictionaries, the world’s premier collection of interactive chemistry databases from CRC Press, Taylor & Francis Group. This means that Alfa Chemistry’s vast catalog of specialized chemicals will be easily discoverable within the premier digital chemistry resource used by researchers and scientists around the world.

Vaxess Presents Data on Development of Needle-Free, Self-Applied Microarray Patch for GLP-1 Delivery

Vaxess Technologies, Inc., a biotech company developing a novel microarray patch technology to transform home delivery of therapies, is presenting new preclinical data at the 2025 American Diabetes Association (ADA) Scientific Sessions in Chicago.

Zymo Research Offers Reliable Domestic Solutions Amid Offshore Supply Chain Challenges

As supply chain instability and international backorders continue to affect the life sciences and diagnostics sectors, Zymo Research is stepping in with scalable, U.S.-based alternatives. Our latest announcement spotlights our domestic manufacturing capabilities and our role as a long-standing OEM and development partner, helping research and clinical labs maintain continuity without compromise. We believe this is especially relevant to your readers, many of whom are actively seeking reliable domestic partners. We invite you to read the full press release here: https://www.zymoresearch.com/blogs/press-releases/supply-chain-challenges

Kindeva joins forces with Rocket Science Health to pioneer new Intranasal Delivery Platform

Alithea Genomics Launches MERCURIUS™ Total DRUG-seq: A Next-Generation Full-Length Transcriptome Profiling Platform for High-Throughput Compound Screening and Target Validation

Alithea Genomics has announced the launch of MERCURIUS™ Total DRUG-seq to push the boundaries of high-throughput drug screens, toxicology screens and target validation.